Advertisement

Frontiers of Medicine

, Volume 11, Issue 1, pp 62–67 | Cite as

Aortic aneurysm and chronic disseminated intravascular coagulation: a retrospective study of 235 patients

  • Yun Zhang
  • Chen Li
  • Min Shen
  • Bao Liu
  • Xuejun Zeng
  • Ti Shen
Research Article
  • 130 Downloads

Abstract

Chronic disseminated intravascular coagulation (DIC) is a rare but devastating complication of aortic aneurysm (AA). This study investigated the clinical manifestations, laboratory findings, and treatment of patients with AA-associated chronic DIC (AA-DIC) and explored the mechanisms, duration, and therapeutic response of AA-DIC. We retrospectively reviewed the medical records of 235 AA patients admitted at the Peking Union Medical College Hospital between September 2009 and January 2015. The patients were classified as those with DIC (AA-DIC) and those without DIC (non-DIC). The AA-DIC group showed a significantly higher proportion of female patients and a significantly longer AA disease course than the non-DIC group did. The AA-DIC patients presented mural thrombi, dissecting aneurysms, a family history of AA, and diabetes significantly more frequently than the non-DIC patients did. Furthermore, multiple regression analyses revealed that sex, mural thrombus, aneurysm type, diabetes, and stent surgery are possible independent risk factors for AA-DIC patients. Fifty-two (22.1%) patients presented AA-DIC. Among these patients, 43 had non-typical DIC and 9 had typical DIC; the mortality rate of the latter was 22.2%. The mean age of the patients with typical DIC was significantly higher than of that of patients with non-typical DIC. The non-typical DIC patients also presented abnormal coagulation disorders of varying degrees. Furthermore, heparin or low-molecular-weight heparin improved the clinical symptoms and laboratory parameters in patients with AA and typical DIC. Thus, chronic DIC should be considered in patients with AA.

Keywords

aortic aneurysm disseminated intravascular coagulation anticoagulation therapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgements

We thank all of our colleagues at the Peking Union Medical College Hospital who were involved in patient care and medical records management and research.

References

  1. 1.
    Kasper DL, Harrison TR. Harrison’s Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Medical Pub Division, 2005Google Scholar
  2. 2.
    Bick RL. Disseminated intravascular coagulation: current concepts of etiology, pathophysiology, diagnosis, and treatment. Hematol Oncol Clin North Am 2003; 17(1): 149–176CrossRefPubMedGoogle Scholar
  3. 3.
    Wada H, Gabazza EC, Asakura H, Koike K, Okamoto K, Maruyama I, Shiku H, Nobori T. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 2003; 74(1): 17–22CrossRefPubMedGoogle Scholar
  4. 4.
    Micallef-Eynaud PD, Ludlam CA. Aortic aneurysms and consumptive coagulopathy. Blood Coagul Fibrinolysis 1991; 2(3): 477–481CrossRefPubMedGoogle Scholar
  5. 5.
    Jelenska MM. Coagulation parameters as predictors of DIC in patients with intact aortic aneurysm. Hamostaseologie 2004; 24(3): 162–166CrossRefPubMedGoogle Scholar
  6. 6.
    Fine NL, Applebaum J, Elguezabal A, Castleman L. Multiple coagulation defects in association with dissecting aneurysm. Arch Intern Med 1967; 119(5): 522–526CrossRefPubMedGoogle Scholar
  7. 7.
    Fernandez-Bustamante A, Jimeno A. Disseminated intravascular coagulopathy in aortic aneurysms. Eur J Intern Med 2005; 16(8): 551–560 PMID:16314235CrossRefPubMedGoogle Scholar
  8. 8.
    Siebert WT, Natelson EA. Chronic consumption coagulopathy accompanying abdominal aortic aneurysm. Arch Surg 1976; 111(5): 539–541CrossRefPubMedGoogle Scholar
  9. 9.
    Taylor FB, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86(5): 1327–1330CrossRefPubMedGoogle Scholar
  10. 10.
    Fisher DF, Yawn DH, Crawford ES. Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg 1983; 118(11): 1252–1255PubMedGoogle Scholar
  11. 11.
    Jimeno A, Toledo T, Moya I, González-Barber A. Chronic disseminated intravascular coagulation caused by an aorto-bife-moral aneurysm. Eur J Intern Med 2005; 16(4): 298–300CrossRefPubMedGoogle Scholar
  12. 12.
    Liu W, Zhang L, Liu Y, Liu X, Xue F, Chen Y, Huang Y, Yang R. Chronic disseminated intravascular coagulopathy associated with aortic dissecting aneurysms: two cases report and literature review. Chin J Hematol (Zhonghua Xue Ye Xue Za Zhi) 2014; 35(9): 831–834 (in Chinese)Google Scholar
  13. 13.
    Levi M, de Jonge E, van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 2004; 36(1): 41–49CrossRefPubMedGoogle Scholar
  14. 14.
    Hoots WK. Non-overt disseminated intravascular coagulation: definition and pathophysiological implications. Blood Rev 2002; 16(Suppl 1): S3–S9CrossRefPubMedGoogle Scholar
  15. 15.
    Straub PW, Kessler S. Metabolism and localization of 131Ifibrinogen in chronic intravascular coagulation. Schweiz Med Wochenschr 1970; 100(46): 2001–2003 (in German)PubMedGoogle Scholar
  16. 16.
    Carroccio A, Ellozy SH, Marin ML, Hollier LH. Ten years’ experience treating abdominal aortic aneurysms with stent-grafts. Adv Surg 2004; 38: 267–280PubMedGoogle Scholar
  17. 17.
    Sakamoto I, Matsuyama N, Fukushima A, Hayashi H, Nishida A, Hazama S, Noguchi M, Eishi K, Hayashi K. Chronic aortic dissection complicated by disseminated intravascular coagulation: successful treatment with endovascular stent-grafting. J Endovasc Ther 2003; 10(5): 953–957CrossRefPubMedGoogle Scholar
  18. 18.
    Aboulafia DM, Aboulafia ED. Aortic aneurysm-induced disseminated intravascular coagulation. Ann Vasc Surg 1996; 10(4): 396–405CrossRefPubMedGoogle Scholar
  19. 19.
    Perry JH, Lazar HL, Quillen K, Sloan JM. Successful long-term management of aneurysm-associated chronic disseminated intravascular coagulation with low molecular weight heparin. J Card Surg 2012; 27(6): 730–735CrossRefPubMedGoogle Scholar
  20. 20.
    Kamineni R, Heuser RR. Abdominal aortic aneurysm: a review of endoluminal treatment. J Interv Cardiol 2004; 17(6): 437–445CrossRefPubMedGoogle Scholar
  21. 21.
    Mueller MM, Bomke B, Seifried E. Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. Thromb Res 2002; 107(Suppl 1): S9–S17CrossRefPubMedGoogle Scholar
  22. 22.
    Tsuji T, Morikawa K, Hirano T, Yamasaki H, Tsuda H. Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection. Rinsho Ketsueki 2013; 54(8): 769–771 (in Japanese)PubMedGoogle Scholar
  23. 23.
    Hoshina K, Kaneko M, Hosaka A, Okamoto H, Shigematsu K, Miyata T. Lessons learned from a case of abdominal aortic aneurysm accompanied by unstable coagulopathy. Case Rep Vasc Med 2012; 2012:265860PubMedPubMedCentralGoogle Scholar
  24. 24.
    Iyama S, Sato T, Murase K, Kamihara Y, Ono K, Kikuchi S, Takada K, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J. Intermittent administration of recombinant human soluble thrombomodulin successfully controlled chronic disseminated intravascular coagulation in a patient with dissecting aortic aneurysm on an outpatient basis. Blood Coagul Fibrinolysis 2012; 23(6): 548–550CrossRefPubMedGoogle Scholar
  25. 25.
    Hayakawa K, Tamura S, Gima H, Hayakawa T, Kurihara T, Ooura M, Nakano Y, Souri M, Ichinose A, Fujimoto T. Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm. Rinsho Ketsueki 2014; 55(11): 2300–2305PubMedGoogle Scholar
  26. 26.
    Hayashi T, Nakagawa N, Kadohira Y, Morishita E, Asakura H. Rivaroxaban in a patient with disseminated intravascular coagulation associated with an aortic aneurysm: a case report. Ann Intern Med 2014; 161(2): 158–159CrossRefPubMedGoogle Scholar
  27. 27.
    Hoshina K, Shigematsu K, Hosaka A, Okamoto H, Miyata T, Watanabe T. The effect of recombinant human soluble thrombomodulin on disseminated intravascular coagulation in an abdominal aortic aneurysm. Blood Coagul Fibrinolysis 2014; 25(4): 389–391CrossRefPubMedGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Yun Zhang
    • 1
  • Chen Li
    • 1
  • Min Shen
    • 2
  • Bao Liu
    • 3
  • Xuejun Zeng
    • 1
  • Ti Shen
    • 4
  1. 1.Department of General Internal Medicine, Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  2. 2.Department of Rheumatology, Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  3. 3.Department of Vascular Surgery, Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  4. 4.Department of Internal Medicine, Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina

Personalised recommendations